An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee Replacement

NCT00859313 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Postoperative

Interventions

DRUG: Sufentanil NanoTab PCA System/15 mcg

Sponsor

Talphera, Inc